866-997-4948(US-Canada Toll Free)

Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets

Published By :

CBR Pharma Insights

Published Date : Jan 2016

Category :

Pharmaceutical

No. of Pages : 86 Pages

GBI Research's latest report, ""Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets"" assesses developments within the key elements of market access such as Health Economics and Outcome Research (HEOR), Health Technology Assessment (HTA) as well as pricing and reimbursements strategies for pharmaceutical products. This new report also discusses the need to integrate market access strategies earlier into the drug development process, in order to save time and costs related to conducting additional studies to prove the added benefits of a product. Additionally, our new study analyses the role of HTAs in market access and alternatives that could be used in cases where there is limited evidence. Detailed analysis of pricing and reimbursement policies in North America, five key European countries and Japan are also included in this report along with a myriad of relevant case studies. In order to gain optimum market access, companies have to analyze the economic benefit of the treatment, the level of competition and the required reimbursement support.

Scope

Payers continue to play an important role in market access. Products are increasingly being rejected for reimbursement, adversely affecting the market share of these products.

  • What strategies can pharmaceutical companies implement in order to overcome these challenges?

HEOR plays a critical part in market access

  • How does HEOR help internal decision making?
  • How can a systemic value development plan (SVDP) optimize HEOR?
  • How do cost-effectiveness analyses play a role in the commercial success of a new product?

HTA has gained importance in reimbursement decisions

  • What are the different concepts and general processes involved in HTA?
  • What are the key benefits of HTA?

Pricing and reimbursement are the key elements of market access

  • What are the most important factors considered in pricing decisions?
  • What are the pricing and reimbursement policies in the US, Canada, UK, Germany, France, Italy, Spain and Japan?

Reasons to buy

This report will allow you to -

Table of Content

Executive Summary

Introduction

Health Economic and Outcomes Research (HEOR)
A Systemic Value Development Plan for HEOR
Types of Economic Evaluations
Overview of Cost-Effectiveness Analysis
Quality-Adjusted Life Year in HEOR
Pharmacoeconomic Modelling Methods
Health Technology Assessment (HTA) in Market Access
Key Benefits of HTA
Process and Dimensions of HTA
Principle HTA Regulatory Agencies
Case Studies
Risk Sharing Agreements When Limited Evidence is Available for HTA 
Pricing and Reimbursement 
Factors Affecting Pricing Decision
Pricing of a New Drug 
Pharmaceutical Pricing Policies in the US
Impact Of Affordable Care Act on Market Access
Case Studies
Pharmaceutical Pricing and Reimbursement Policies in Canada
Pharmaceutical Pricing and Reimbursement Policies in Europe (UK, Germany, France, Italy and Spain)
Case Studies
Parallel Trade in Europe
Pharmaceutical Pricing and Reimbursement Policies in Japan
Economic Analysis Alongside Clinical Trials
Harmonization of Drug Approval and Marketing for Effective Market Access
Key Challenges for Achieving Optimum Market Access
Key Takeaways

List of Table

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Mexico Digital Radiology Market: Industry Size, Market Share, Trends,Analysis And Forecasts 2012 - 2018

    SCOPE OF THE REPORT This report is an effort to identify factors, which will be the driving force behind the digital radiology market and sub-markets in the next six years. This report is specially designed to estimate and analyze the demand and performance of Mexican digital radiology market. The report provides extensive analysis of the digital radiology industry, current market trends, industry drivers and challenges for better unde...

  • Global Vaccine Market Analysis and Forecast 2011-2016

    The report contains the global scenario of Vaccine market discussing its details and market figures. The report provides market size and forecast till 2016 for each segment and geography across the globe. It also describes the key influencing factors for the global vaccine market.  The report lists mergers & acquisitions among the major players along with key product developments in the market. The report also provides information a...

  • B-Type Natriuretic Peptide Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    B-type natriuretic peptides, also called, brain natriuretic peptide, is a 32-amino acid (AA) polypeptide, which is produced by ventricles of the heart, as a reflex action to over-stretching of cardiac muscles cells. The generation of BNP is controlled by calcium ions. BNP and ANP (atrial natriuretic peptide) are working similarly and the physiological action of both is similar. The important function of ANP and BNP is to decrease the systemic vas...